Your browser doesn't support javascript.
loading
Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis.
van Rijn, S P; Zuur, M A; van Altena, R; Akkerman, O W; Proost, J H; de Lange, W C M; Kerstjens, H A M; Touw, D J; van der Werf, T S; Kosterink, J G W; Alffenaar, J W C.
Afiliación
  • van Rijn SP; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Zuur MA; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • van Altena R; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Akkerman OW; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Proost JH; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
  • de Lange WC; University of Groningen, Groningen Research Institute of Pharmacy, Section Pharmacokinetics, Toxicology and Targeting, Groningen, The Netherlands.
  • Kerstjens HA; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Touw DJ; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
  • van der Werf TS; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Kosterink JG; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Alffenaar JW; University of Groningen, Groningen Research Institute of Pharmacy, Section Pharmacokinetics, Toxicology and Targeting, Groningen, The Netherlands.
Antimicrob Agents Chemother ; 61(4)2017 04.
Article en En | MEDLINE | ID: mdl-28137814
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Modelos Estadísticos / Beta-Lactamas / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Modelos Estadísticos / Beta-Lactamas / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos